Russell Johnson

Executive Director, Independent Expert

Russell Johnson is a senior leader in RNA delivery and formulation with 15+ years of industry experience. He focuses on advancing LNP and biopharmaceutical technologies for RNA therapeutics across infectious disease, cancer, and rare diseases. His work spans platform development, early-stage innovation, and leadership in RNA drug delivery systems.

Seminars

Wednesday 18th November 2026
Industry Leader’s Fireside Chat: The Next Decade of LNP Characterization, Which Analytical Technologies Will Shape the Future of RNA Medicines?
9:00 am
  • Which analytical technologies are generating the most excitement?
  • What are the biggest characterization gaps today?
  • Are we measuring the right CQAs?
  • How will AI and automation transform analytical development?
  • Which technologies will become standard over the next 5-10 years?
Russel Johnson